Also listed on Novozymes, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 22, 2027 · High confidence
20-year base term ended Dec 23, 2022
Held by Novozymes Biopharma DK A/S
Filed Feb 11, 2004 as application 10/775,204 · Granted Nov 28, 2006
Base term plus 4 days of patent term adjustment (USPTO delay)
Today
2002
2027
Clock starts
Dec 23, 2002
Dec 23, 2002
Term ends
Apr 22, 2027
Apr 22, 2027
Granted
Nov 28, 2006
Nov 28, 2006
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
4
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
32
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 4 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 23, 2002, when application PCT/US2002/040891, the earliest non-provisional in its chain, was filed (this one was filed Feb 11, 2004) | Dec 23, 2022 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +4 days, USPTO patent term adjustment record | Dec 27, 2022 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1577 days, USPTO 35 U.S.C. 156 certificate | added to Dec 27, 2022: Apr 22, 2027 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 22, 2027 | High confidence |
This family
| Application PCT/US2002/040891 | PCT application no patent term | no patent term |
| Application PCT/US2004/001369 | PCT application no patent term | no patent term |
| US 7,141,547 | this patent Apr 2027 | Apr 2027 |
| Application PCT/US2005/004041 | PCT application no patent term | no patent term |
| US 7,521,424 | Term ended Dec 2022 | Dec 2022 |
| US 7,592,010 | Term ended Dec 2023 | Dec 2023 |
| US 7,238,667 | Term ended Dec 2022 | Dec 2022 |
| US 7,847,079 | Lapsed on the fee record Dec 2018 | Dec 2018 |
8 of 32 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 17, 2004 Reel 14740, frame 651 | Rosen, Craig A.; Haseltine, William A. | Human Genome Sciences, Inc. | Assignment of Assignor's Interest |
| Jun 17, 2004 Reel 14747, frame 948 | Ballance, David J.; Turner, Andrew J | Delta Biotechnology Limited | Assignment of Assignor's Interest |
| Apr 26, 2005 Reel 16494, frame 459 | Ruben, Steven M. | Human Genome Sciences, Inc. | Assignment of Assignor's Interest |
| Feb 24, 2012 Reel 27761, frame 772 | Novozymes Delta Limited | Novozymes Biopharma UK Limited | Change of Name |
| Feb 24, 2012 Reel 27761, frame 861 | Novozymes Biopharma UK Limited | Novozymes Biopharma DK A/S | Assignment of Assignor's Interest |
| Feb 24, 2012 Reel 27761, frame 898 | Delta Biotechnology Limited | Novozymes Delta Limited | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2027
Term ends Apr 22, 2027. No further fees fall due before then
Note
The 4 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
241
later US patents cite this one
That is top 5% of utility patents granted in 2006 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.